Topical CBD Recall: Broadway Joe's Pain Cream
Announced 2026-09-09 · FDA
FDA recalls Lexia LLC Broadway Joe's Pain Cream due to CGMP deviations and potential contamination of raw material. About 1,200 four-ounce jars distributed in Colorado are affected, covering Lot numbers T1110–T1114 with Expiration dates from 1/7/2027 to 1/17/2027. No corrective action information is provided in the recall notice.
| Brand | Lexia LLC |
|---|---|
| Product | Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-6; UPC 8 50041 64004 4 |
| Reason | CGMP Deviations: Potential contamination of raw material |
| Severity | moderate |
| Units affected | 2400 |
| Distribution | Distributed in the state of Colorado (US). |
| Agency | FDA |
| Recall / campaign no. | Lot #: T1110, Exp: 1/7/2027; T1111, Exp: 1/9/2027; T1112, Exp: 1/16/2027; T1113, Exp: 1/17/2027; T1114, Exp: 1/17/2027 |
WHAT YOU SHOULD DO
- Do not use any product from the affected lots (T1110–T1114) and check your packaging for lot and expiry dates.
- Contact the retailer or Lexia LLC for instructions on return, refund, or disposal of the affected product.
- If you have used the product and have concerns or symptoms, seek medical advice and report any adverse effects to the appropriate health authorities.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.